Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer

References

• Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467
   PubMedGoogle Scholar
• Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 2007;42:120–128
   PubMed Web of Science ®Google Scholar
• Mroczko B, Groblewska M, Łukaszewicz-Zajac M, Kedra B, Szmitkowski M. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients. Clin Chem Lab Med 2009;47:1133–1139
   PubMed Web of Science ®Google Scholar
• Mroczko B, Wereszczynska-Siemiatkowska U, Groblewska M, Lukaszewicz M, Szmitkowski M, Gryko M, Kedra B. The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients. Clin Chim Acta 2006;374:165–167
   PubMed Web of Science ®Google Scholar
• Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008;85:87–100
   PubMed Web of Science ®Google Scholar
• Ilhan N, Ilhan Y, Akbulut H, Kucuksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 2004;10:1115–1120
   PubMed Web of Science ®Google Scholar
• Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 2009;9:155
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161
   PubMed Web of Science ®Google Scholar
• Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, Tanaka S, Ohmoto Y, Chayama K. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res 2005;25:709–713
   PubMed Web of Science ®Google Scholar
• Tekbas E, Kara AF, Ariturk Z, Cil H, Islamoglu Y, Elbey MA, Soydinc S, Ulgen MS. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest 2011;71:613–619
   PubMed Web of Science ®Google Scholar
• Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23–28
   PubMed Web of Science ®Google Scholar
• Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemiccerebrovascular events? Stroke 2004;35:1688–1691
   PubMed Web of Science ®Google Scholar
• Ekiz F, Yüksel O, Koçak E, Yilmaz B, Altınbaş A, Çoban Ş, Yüksel I, Üsküdar O, Köklü S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25:162–165
   PubMed Web of Science ®Google Scholar
• Yüksel O, Helvaci K, Başar O, Köklü S, Caner S, Helvacı N, Abayli E, Altiparmak E. An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume. Platelets 2009;20:277–281
   PubMed Web of Science ®Google Scholar
• Ekiz F, Gürbüz Y, Basar O, Aytekin G, Ekiz O, Sentürk GC, Aktas B, Yilmaz B, Altinbas A, Coban S, et al. Mean platelet volume in the diagnosis and prognosis of crimean-congo hemorrhagic fever. Clin Appl Thromb Hemost. 2012 Mar 19. [Epub ahead of print]
   Google Scholar
• Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, Tenlik I, Kalkan IH, Beyazit Y, Yuksel O. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol 2013;37:41–46
   PubMedGoogle Scholar
• Purnak T, Efe C, Yuksel O, Beyazit Y, Ozaslan E, Altiparmak E. Mean platelet volume could be a promising biomarker to monitor dietary compliance in celiac disease. Ups J Med Sci 2011;116:208–211
   PubMed Web of Science ®Google Scholar
• Kurt M, Onal IK, Sayilir AY, Beyazıt Y, Oztaş E, Kekilli M, Turhan N, Karaman K, Akdogan M. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 2012;59:1580–1582
   PubMed Web of Science ®Google Scholar
• Karaman K, Bostanci EB, Aksoy E, Kurt M, Celep B, Ulas M, Dalgic T, Surmelioglu A, Hayran M, Akoglu M. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med 2011;22:95–98
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–1474
   PubMed Web of Science ®Google Scholar
• Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, Kondo T, Kikuchi S, Toyoshima H, Hayakawa N, et al; Japan Collaborative Cohort Study Group. Prospective study of screening for stomach cancer in Japan. Int J Cancer 2003;106:103
   PubMedGoogle Scholar
• Llorens P. Gastric cancer mass survey in Chile. Semin Surg Oncol 1991;7:339
   PubMedGoogle Scholar
• Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. Case-control study of gastric cancer screening in Venezuela. Br J Cancer 1994;69:1102
   PubMedGoogle Scholar
• Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002; 22:2311
   PubMed Web of Science ®Google Scholar
• Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002;49:1157
   PubMed Web of Science ®Google Scholar
• Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008;85:87–100
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007;121:2373–2380
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, De Vita F, Romano C, Orditura M, Castellano P, Imperatore V, Infusino S, Catalano G, Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: Relationship with radicality and outcome. J Interferon Cytokine Res 2002;22:473–482
   PubMed Web of Science ®Google Scholar
• Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58:1008–1015
   PubMed Web of Science ®Google Scholar
• Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, Aoki T, Aoki T. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor. Gastric Cancer 2005;8:124–131
   PubMedGoogle Scholar
• Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK, Chi CW. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996;91:1417–1422
   PubMed Web of Science ®Google Scholar
• Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, Wang SY. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 2002;63:64–69
   PubMed Web of Science ®Google Scholar
• Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B. Platelet activation in patients with advanced gastric cancer. Neoplasma 2010;57:145–150
   PubMed Web of Science ®Google Scholar